Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
- Patients must be undergoing diagnostic biopsy or resection of their primary or
metastatic bone sarcoma for therapeutic purposes.
- The specimen must be large enough to allow routine pathological analysis, with the
specimen for research excised from residual tissue that would otherwise be discarded.
Type of Study:
Observational Model: Case-Only, Time Perspective: Prospective
To establish a serial ascertainement of specimens from patients with bone sarcomas to be used in ongoing cytogenetic and molecular genetic analyses.
Outcome Time Frame:
conclusion of study
Marc Ladanyi, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
- Lung Cancer
- Soft Tissue
- Lung Neoplasms
|Memorial Sloan-Kettering Cancer Center
||New York, New York 10021